Adlai Nortye ANL
NASDAQ ANL
$15.01 +0.26 (+1.76%)
At close: Sep 4, 2026 · 4:00 PM EDT

Adlai Nortye (ANL) Accounts Payables (2022 - 2026)

Adlai Nortye (ANL) posted quarterly Accounts Payables of $12.6 million for Q4 2025, up 24.56% year-over-year from $10.1 million in Q4 2024, and up 30.58% quarter-over-quarter from $9.7 million in Q2 2025.

Analysis

Adlai Nortye (ANL) Accounts Payables (2022 - 2026) Analysis & Trends

Adlai Nortye (ANL) has reported Accounts Payables for 4 consecutive years, with $12.6 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Accounts Payables rose 24.56% year-over-year to $12.6 million; the TTM figure through Dec 2025 stood at $12.6 million (up 24.56% YoY), while the FY2025 annual figure was $12.6 million, up 24.56% from the prior year.
  • Accounts Payables advanced to $12.6 million in Q4 2025 per ANL's latest filing, from $9.7 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $14.3 million in Q4 2023 and bottomed at $9.7 million in Q2 2025.
  • Historically, Accounts Payables has averaged $11.8 million across 4 years, with a median of $11.8 million in 2024.
  • Annual changes were most pronounced in 2024 — Accounts Payables declined 29.29% — and 2025, when it gained 24.56%.
  • Adlai Nortye's Accounts Payables stood at $13.1 million in 2022, then rose by 9.54% to $14.3 million in 2023, then slipped by 29.29% to $10.1 million in 2024, then advanced by 24.56% to $12.6 million in 2025.
  • Business Quant data shows ANL's Accounts Payables at $12.6 million in Q4 2025, $9.7 million in Q2 2025, and $10.1 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 429.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.16 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.52 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 167.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 88.42 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 470.30 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 108.02 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 35.57 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 428.93 Mn
10 Adlai Nortye 500.08 Mn 268.19 Mn - 4.61 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.61 Mn
Dec 31, 2025 12.64 Mn
Jun 30, 2025 9.68 Mn
Dec 31, 2024 10.15 Mn
Jun 30, 2024 11.00 Mn
Dec 31, 2023 14.35 Mn
Dec 31, 2022 13.10 Mn